P414: RNA MODIFICATION-FOCUSED CRISPR-CAS9 SCREEN REVEALS POTENTIAL THERAPEUTIC TARGETS MEDIATING CHEMORESISTANCE IN AML. (23rd June 2022) - Kienhöfer, M.; Pauli, C.; Delaunay, S.; Rohde, C.; Blank, M. F.; Heid, D.; Frye, M.; Müller-Tidow, C.